Non-invasive PD-L1 quantification using [18F]DK222-PET imaging in cancer immunotherapy
Non-invasive PD-L1 quantification using [18F]DK222-PET imaging in cancer immunotherapy
About this item
Full title
Author / Creator
Publisher
England: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
BackgroundCombination therapies that aim to improve the clinical efficacy to immune checkpoint inhibitors have led to the need for non-invasive and early pharmacodynamic biomarkers. Positron emission tomography (PET) is a promising non-invasive approach to monitoring target dynamics, and programmed death-ligand 1 (PD-L1) expression is a central com...
Alternative Titles
Full title
Non-invasive PD-L1 quantification using [18F]DK222-PET imaging in cancer immunotherapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_7856009de17747f48b0f6f8e7f6db401
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7856009de17747f48b0f6f8e7f6db401
Other Identifiers
ISSN
2051-1426
E-ISSN
2051-1426
DOI
10.1136/jitc-2023-007535
